DrugStudies America

Marietta, Georgia 30066

2 studies enrolling now · 52 studies all time

What they study most

Acute Migraine, Analgesia, Arthritis, Rheumatoid, Chronic Low Back Pain, Chronic Lower Back Pain, Chronic Noncancer Pain, Chronic Osteoarthritis Pain, Chronic Pain, Degenerative Disc Disease, Dyslipidemias, Fibromyalgia, Hot Flashes

Studies at this site

• A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery — Completed
• Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain — Completed
• A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause — Completed
• Electrical Nerve Block for Amputation Pain — Running, not enrolling
• Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee — Stopped early
• Extended and Controlled Release Liposomal Formulated Dexamethasone for Chronic Knee OA Pain — Completed
• INTRACEPT: Prospective, Randomized, Multi-center Study Intraosseous Basivertebral Nerve Ablation for Treatment of CLBP — Completed
• Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain — Completed
• Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip — Completed
• Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL — Paused
• Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee — Stopped early
• AP-003-C Study to Confirm the Efficacy of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the Knee — Completed
• A Phase 3 Efficacy and Safety Study of Intra-articular CNTX-4975-05 (Capsaicin) vs Placebo in Subjects With OA Knee Pain — Completed
• Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain — Completed
• A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
• Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• A Study of Single and Repeat Dose Administration of UBX0101 in Patients With Osteoarthritis of the Knee — Completed
• Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain — Completed
• A Phase 3 Study of Tanezumab for Chronic Low Back Pain — Completed
• Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone — Completed
• Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee — Completed
• A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia — Stopped early
• Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone — Completed
• Exploratory Study of PENNSAID Gel to Treat Symptoms of Knee Osteoarthritis — Completed
• A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain — Stopped early
• Long-term Open-Label Safety Study to Evaluate EN3409 — Completed
• Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time — Completed
• Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time — Completed
• A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain — Completed
• Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects — Completed
• Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects — Completed
• PF-06372865 In Subjects With Chronic Low Back Pain — Completed
• Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain — Completed
• Intradiscal rhGDF-5 Phase I/II Clinical Trial — Completed
• A Multicenter, Randomized, Double-blind, Placebo Controlled, Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of 2 Doses of Intradiscal rhGDF-5 (Single Administration) for the Treatment of Early Stage Lumbar Disc Degeneration — Completed
• Crossover Post-herpetic Neuralgia (PHN) — Completed
• Study of Diclofenac Capsules to Treat Osteoarthritis Pain — Completed
• Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain — Completed
• Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain — Completed
• Hymovis™ Versus Placebo in Knee Osteoarthritis — Completed
• A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee — Completed
• Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain — Stopped early
• Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain — Stopped early
• Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain — Completed
• Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain — Completed
• Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. — Completed
• A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia. — Completed